Star Health & Allied Insurance Company Ltd
Star Health & Allied Insurance Ltd (Star) is India’s first Standalone Health Insurance provider and is the largest private health insurer in India with a market share of 15.8% in the Indian health insurance market in FY21 with leadership in the attractive retail health segment.[1]
- Market Cap ₹ 29,617 Cr.
- Current Price ₹ 503
- High / Low ₹ 534 / 341
- Stock P/E 66.4
- Book Value ₹ 127
- Dividend Yield 0.00 %
- ROCE 12.0 %
- ROE 9.37 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 18.6% CAGR over last 5 years
Cons
- Stock is trading at 3.98 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,069 | 1,595 | 2,012 | 2,888 | 3,775 | 4,987 | 5,050 | 10,602 | 12,096 | 14,021 | 16,101 | 17,258 | |
| 1,189 | 1,439 | 1,871 | 2,673 | 3,565 | 4,544 | 6,447 | 11,962 | 11,223 | 12,840 | 15,180 | 16,668 | |
| Operating Profit | -120 | 156 | 141 | 215 | 210 | 443 | -1,397 | -1,360 | 873 | 1,182 | 921 | 590 |
| OPM % | -11% | 10% | 7% | 7% | 6% | 9% | -28% | -13% | 7% | 8% | 6% | 3% |
| 0 | 0 | 0 | 0 | 0 | 0 | -3 | 7 | 5 | 6 | 11 | 12 | |
| Interest | 1 | 2 | 3 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 19 | 18 | 20 | 23 | 28 | 29 | 46 | 43 | 52 | 59 | 71 | 0 |
| Profit before tax | -140 | 137 | 118 | 171 | 182 | 413 | -1,446 | -1,397 | 826 | 1,129 | 861 | 602 |
| Tax % | 0% | 0% | 0% | 1% | 30% | 35% | -25% | -25% | 25% | 25% | 25% | |
| -140 | 137 | 118 | 170 | 128 | 268 | -1,086 | -1,041 | 619 | 845 | 646 | 446 | |
| EPS in Rs | -3.87 | 3.53 | 2.59 | 3.73 | 2.81 | 5.46 | -19.81 | -18.08 | 10.63 | 14.44 | 10.99 | 7.59 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 26% |
| 3 Years: | 15% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 19% |
| 3 Years: | 38% |
| TTM: | -43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -5% |
| 1 Year: | 29% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 0% |
| 3 Years: | 12% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 362 | 387 | 456 | 456 | 456 | 491 | 548 | 576 | 582 | 585 | 588 | 588 |
| Reserves | -220 | -27 | 334 | 504 | 773 | 1,153 | 2,947 | 4,045 | 4,862 | 5,799 | 6,471 | 6,857 |
| 0 | 0 | 0 | 250 | 250 | 250 | 250 | 720 | 470 | 470 | 470 | 470 | |
| 954 | 1,012 | 1,423 | 2,138 | 3,394 | 4,233 | 6,756 | 8,174 | 9,313 | 10,914 | 13,255 | 13,354 | |
| Total Liabilities | 1,096 | 1,372 | 2,213 | 3,347 | 4,872 | 6,127 | 10,501 | 13,514 | 15,226 | 17,768 | 20,785 | 21,270 |
| 46 | 62 | 77 | 92 | 85 | 90 | 183 | 113 | 217 | 159 | 161 | 190 | |
| CWIP | 12 | 3 | 7 | 5 | 13 | 12 | 19 | 4 | 10 | 16 | 24 | 0 |
| Investments | 502 | 807 | 1,428 | 2,165 | 3,030 | 4,290 | 6,733 | 11,373 | 13,276 | 15,491 | 17,898 | 18,672 |
| 535 | 500 | 700 | 1,085 | 1,744 | 1,735 | 3,565 | 2,024 | 1,723 | 2,102 | 2,701 | 2,407 | |
| Total Assets | 1,096 | 1,372 | 2,213 | 3,347 | 4,872 | 6,127 | 10,501 | 13,514 | 15,226 | 17,768 | 20,785 | 21,270 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 321 | 557 | 776 | 647 | 890 | 56 | 1,276 | 1,310 | 1,379 | |||
| -497 | -663 | -731 | -1,006 | -2,418 | -3,786 | -1,097 | -1,177 | -1,151 | |||
| 310 | 249 | 333 | 122 | 2,613 | 2,509 | -268 | 23 | -4 | |||
| Net Cash Flow | 134 | 143 | 379 | -237 | 1,086 | -1,221 | -89 | 156 | 224 | ||
| Free Cash Flow | 283 | 521 | 746 | 614 | 844 | -7 | 1,229 | 1,187 | 1,297 | ||
| CFO/OP | 228% | 260% | 397% | 168% | -70% | -4% | 145% | 119% | 170% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | |||||||||||
| Days Payable | |||||||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -255 | -179 | -191 | -196 | -260 | -238 | -397 | -258 | -255 | -249 | -261 |
| ROCE % | 55% | 21% | 19% | 14% | 25% | -51% | -31% | 15% | 18% | 12% |
Insights
In beta| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Number of Lives Covered Crore |
|
|||||||
| Retail Health Market Share % |
||||||||
| Network Hospitals absolute |
||||||||
| Number of Licensed Agents absolute |
||||||||
| Number of Branches absolute |
||||||||
| Claims Settled (Annual/YTD) Million |
||||||||
| Average Sum Insured - Retail Fresh INR Lacs |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement Under SEBI (LODR) Regulations, 2015
6 Apr - IRDAI approved transmission of 8,28,82,958 shares held by late Rakesh Jhunjhunwala on April 6, 2026.
-
Announcement under Regulation 30 (LODR)-Credit Rating
2 Apr - Care Ratings reaffirmed Star Health’s AA+ Stable issuer rating and AA Stable subordinate debt rating.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2 Apr - Submitted Regulation 74(5) compliance certificate for quarter ended March 31, 2026.
-
Board Meeting Intimation for Declaration Of Audited Financial Results For The Quarter And Year Ended March 31, 2026.
30 Mar - Star Health board meeting on April 28, 2026 to approve FY2025-26 standalone audited results and financials.
- Closure of Trading Window 27 Mar
Annual reports
Concalls
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025Transcript PPT REC
-
Apr 2025TranscriptAI SummaryPPT
-
Jan 2025Transcript PPT
-
Jan 2025TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT
-
Jun 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT REC
-
Jul 2023TranscriptAI SummaryPPT
-
May 2023Transcript PPT
-
Mar 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
Market Share - H1FY26[1]
Retail Health Insurance - 32%
Gross Written Premium - Rs 8,332 Cr
As on December 2024, it holds a 44% market share among standalone health insurers (SAHI) and 13% of the overall insurance market.[2]